Pharmaceutical Anti-Counterfeiting Technologies Market, 2015-2025 - Pharmaceuticals Supply Chains are Highly Complex and Therefore Make it an Ideal Target for Counterfeiters

DUBLIN, Nov. 03, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/gtlhbw/pharmaceutical) has announced the addition of the "Pharmaceutical Anti-Counterfeiting Technologies Market, 2015-2025" report to their offering.

The problem of counterfeit products has been a common challenge to all the industries across the globe. However, when it comes to the pharmaceutical industry, the issue primarily revolves around the health of patients rather than revenue losses in the industry. Counterfeit drugs create substantial public health hazards and cause crucial safety concerns. Falsified or substandard drugs can lead to adverse reactions / side effects and consequently lead to the death of a patient.

The report covers multiple aspects such as key features of various technologies, scenario based future outlook of the market, SWOT analysis and our opinion on the likely drivers which will influence the market's evolution. We have provided a holistic view of the market landscape including detailed profiles of leading technologies highlighting the process by which they prevent counterfeiting. Further advancements in such technologies will make them more cost effective, encourage a wider adoption and result in a more mature market in the years to come.

The Pharmaceutical Anti-Counterfeiting Technologies, 2015-2025' report provides a comprehensive study of the growing market of anti-counterfeiting technologies being used in the pharmaceutical industry. This study provides extensive details on technologies which offer overt and covert features to enable verification of drugs. In addition, it reviews the different track and trace technologies which enable tracking of a product through the supply chain. Counterfeiting of products is a big concern in several industries such as electronics, cosmetics, tobacco, wine & spirits and fast moving consumer goods. Specifically, within the pharmaceutical market, the magnitude of the problem is relatively high as it has a direct impact on the health of the wider community. It is worth highlighting that the pharmaceutical market is highly attractive for counterfeiters due to several benefits such as high price of patented drugs, lack of proper legislations and high demand of medicines compared to their supply. The primary goal of anti-counterfeiting technologies is to prevent counterfeiting of products; this is done by making it difficult to copy patent protected drugs as well as preventing entry of substandard or fake drugs into the product supply chain.

In addition to the key benefits and the likely market drivers, this study also highlights some of the challenges associated with the use and implementation of these technologies in the pharmaceutical industry. Certain technologies require modifications in existing production processes and present operational challenges to the manufacturers. Cost is another factor that can significantly restrain the market.

The report also includes two case studies on serialisation. We have looked at the regulations that have been implemented already or are likely to be implemented to prevent counterfeiting. Most of these regulations favour item level serialisation as a task to be accomplished by the pharmaceutical manufacturers in the near future. However, some stakeholders are of the opinion that authentication technologies are much more effective as anti-counterfeiting measures rather than just providing a unique number to each product (the case of serialisation). The report covers various techniques and measures that have the potential to combat the challenges related to counterfeit medicines.

The scenario based forecast approach identifies short-midterm and long term market evolution for the period 2015-2020 and 2020-2025, respectively. The research, analysis and insights presented in this report are backed by a deep understanding of key insights gathered from both secondary and primary research.

Example Highlights:

• During our research, we identified over 100 technologies (including both authentication and track & trace technologies) developed by over 70 different companies. The landscape seems to be fairly well distributed between authentication and track & trace technologies. Due to the versatility of these technologies, they have wider applications in other industries making it highly lucrative for the current stakeholders.
• Some solutions offer multiple features covering all forms of anti-counterfeiting approach; examples include N'Crypt (Amcor), CATS (Authentix), digital DNA (Applied DNA Sciences), nonclonable ID (Bilcaretech), TruTag Platform (TruTag Technologies) and Microparticle Technology (Stealth Mark).
• As an industry, the focus seems to be divided between authentication and serialisation technologies; stakeholders view this both as a challenge as well as an opportunity to foster further innovation.There is a wider consensus that puts the onus back on different stakeholders to work collaboratively so that the opportunities can be monetised at a rapid pace; this will result in more robust and complex solutions likely to provide the required security to consumers and companies alike.
• Many regions, including the EU and the US, have passed legislations that make serialisation mandatory for every pharmaceutical product. It is a very promising move that is likely to result in a paradigm shift in the way supply chains are managed today. However, there are several implementation hurdles which are expected to result in delays, providing a window of opportunity to the counterfeiters to take advantage of.
• It is a known fact that most of counterfeiting happens in India and China. Though the focus on emerging markets has been relatively week so far, manufacturing companies are expected to increase their attention to deploy anti-counterfeiting technologies for products being manufactured or intended to be launched in these regions; going forward, we expect these markets to play a more prominent role in the overall growth of the opportunity.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Authentication: Key Players and Technologies

6. Track And Trace: Key Technologies and the Concept of Serialisation

7. Market Forecast

8. Swot Analysis

9. Interview Transcripts

10. Conclusion

11. Appendix 1: Tabulated Data

12. Appendix 2: Companies and Organisations Listed

Companies Mentioned

- 3M
- 3S Simons Security Systems
- ACG-Worldwide
- Acsis
- Alcan Packaging
- Alien Technology
- Alliance for Safe Online Pharmacies
- AlpVision
- Amcor
- Amgen
- Applied DNA Sciences
- Atlantic Zeiser
- Authentix
- Avery Dennison
- Axway
- Ball Packaging
- Bilcaretech
- Biocode
- Bosch Packaging Technology
- Canadadrugs.com
- Catalent Pharma
- Cellular Bioengineering
- Central Anti-Counterfeiting Laboratory
- Chesapeake (Acquired by The Carlyle Group)
- Cognizant
- Confidex
- Coresonant
- Covectra
- Deutsche Welle
- DiNova Venture Capital
- DNA Technologies
- Dupont
- Eli Lilly and Company
- EM Microelectronics
- European Alliance of Access to Safe Medicines
- European Medicines Agency
- Everest Holovisions
- Flint Group
- Genzyme
- Green Project Inc
- IC-Tag Solutions
- Impinj
- InfraTrac
- Ingenia Technology
- InkSure Technologies
- Intermec
- International Medical Product Anti-Counterfeiting Task Force (IMPACT)
- Interpol
- Invengo
- Isotag
- ITW Pillar Technologies
- Jura JSP
- Klocke Group
- Kutterer&Mauer AG
- Lab-ID
- Laxcen
- LinkSmart Technologies
- Maryland School of Pharmacy
- Merck
- Merck Serono
- MetalCraft
- Micros Chip
- MicroTagTemed Ltd.
- Microtrace Solutions
- Mobia Solutions
- mPedigree
- Nano 4 U
- National Association of Boards of Pharmacy
- Neosid
- North America Security Products Organisation Company
- NovaVision
- Novo Nordisk
- Oat Systems
- Office of Criminal Investigations
- Omni ID
- Omnia
- Ortho biotech
- Ortho-McNeil Pharmaceuticals
- Pacific Holovisions
- Permanent Forum on International Pharmaceutical Crime (PFIPC)
- Pfizer
- PharmaSecure
- PhotoSecure
- Portalis
- PTS Intermediate Holdings LLC
- Raumedic
- Recipharm
- Rehau Group
- Robert Bosch GmbH
- Saffron Hill Ventures
- Sanofi Aventis
- Schreiner ProSecure
- SecureRF
- SecureSpin Systems
- Sekuworks
- Siemens
- SKAI Ventures
- Smartrac
- Sproxil
- Stealth Co. Inc
- Stealth Mark
- Tagsys
- Themis Medicare
- Thermo Scientific
- TopFlight Corporation
- Total Brand Security
- TraceLink Inc
- TruTag Technologies
- United States Food and Drug Administration
- Universal Postal Union
- Universal Corporation Limited
- UPM Raflatac
- Verify Brands
- Videojet
- ViiV Healthcare
- Vordata
- Wave-Logic
- WaveTrend
- Wellness Center USA Inc
- Wendell Smith
- World Customs Organisations
- World Health Organisation
- WuXiPharmaTech
- Xerafy
- Zebra Technologies

For more information visit http://www.researchandmarkets.com/research/gtlhbw/pharmaceutical

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com